Publications

1. Package advice in practice - Deliberations for arriving at a fair package

   The public debate pays a lot of attention to how we can continue to pay for health care in the future. A question that the ...

   Report | 11-09-2018

2. Semaglutide (Ozempic®) for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise

   The National Health Care Institute carried out a marginal assessment of whether semaglutide (Ozempic®) is interchangeable with a ...

   Report | 28-08-2018

3. Working method for the Zinnige Zorg (appropriate care) Programme

   The National Health Care Institute’s motto is "Taking care of good health care: no more and no less than necessary". Every ...

   Brochure | 27-08-2018

4. Zinnige Zorg implementation of the appropriate care of expensive drugs in cases of castration-refractory prostate cancer (CRPC)

   This letter is to inform the Minister of Medical Care and Sport about the changes made by parties during the implementation phase ...

   Letter | 23-08-2018

5. Hydrocortisone sodium phosphate (Softacor®) for the treatment of mild non-infectious allergic or inflammatory conjunctival diseases

   Zorginstituut Nederland has carried out an assessment of the medicinal product hydrocortisone sodium phosphate (Softacor®) can be ...

   Report | 06-08-2018

6. Zinnige Zorg room for improvement analysis: Peripheral Arterial Disease

   This Room for Improvement Analysis describes the research and the resulting actions and agreements that focus on further ...

   Report | 01-08-2018

7. Roflumilast (Daxas®) for maintenance treatment of severe chronic obstructive lung disease (COPD)

   The National Health Care Institute has carried out an assessment of whether roflumilast (Daxas®) is interchangeable with a drug ...

   Report | 31-07-2018

8. SGLT2 inhibitors for the treatment of type 2 diabetes: relaxing List 2 conditions

   The National Health Care Institute has carried out a substantive assessment of whether the existing list 2 conditions for SGLT2 ...

   Report | 31-07-2018

9. Teduglutide (Revestive®) for the treatment of short bowel syndrome

   The Minister of Health, Welfare and Sport (VWS) has asked the National Health Care Institute to carry out an assessment of ...

   Report | 31-07-2018

10. Obeticholic acid (Ocaliva®) for the treatment of primary biliary cholangitis

    The National Health Care Institute carried out an assessment of whether obeticholic acid (Ocaliva®) is interchangeable with a ...

    Report | 18-07-2018